{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-047422","form_type":"8-K","ticker":"INDP","cik":"0001857044","company_name":"Indaptus Therapeutics, Inc.","filed_at":"2024-11-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.098671+00:00","generated_at":"2026-05-29T19:56:59.935317+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Indaptus Therapeutics prices $2.135M offering of stock and warrants at $1.175/unit","bullets":["Sold 1,817,017 shares of common stock and warrants to buy 1,817,017 shares at $1.175 per unit.","Warrants exercisable at $1.05/share, immediately exercisable, 5-year term; gross proceeds ~$2.135M.","CEO participating, purchasing 42,553 shares and warrants on same terms as other investors.","Funds to be used for R&D, working capital, and general corporate purposes.","Closing expected November 25, 2024; Paulson Investment Company acting as exclusive placement agent."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-047422","json":"https://secwatch.observer/filing/0001493152-24-047422.json","markdown":"https://secwatch.observer/filing/0001493152-24-047422.md","text":"https://secwatch.observer/filing/0001493152-24-047422.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1857044/000149315224047422/0001493152-24-047422-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1857044/000149315224047422/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T19:56:59.935317+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}